Duration of immunity to experimental infection with bovine respiratory syncytial virus following intranasal vaccination of young passively immune calves

Journal of the American Veterinary Medical Association

Volumn 243, Issue 11, 2013, Pages 1602-1608

  Ellis, John A ^a   Gow, Sheryl P ^a   Mahan, Suman ^b   Leyh, Randy ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b ZOETIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CATTLE; CATTLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; IMMUNOLOGY; PASSIVE IMMUNIZATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIROLOGY; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; CATTLE; CATTLE DISEASES; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, BOVINE; VIRUS SHEDDING;

EID: 84888084529     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.243.11.1602     Document Type: Article

References (35)

1. Stokka GL. Prevention of respiratory disease in cow/calf operations. Vet Clin North Am Food Anim Pract 2010;26:229-241.
2. Gorden PJ, Plummer P. Control, management, and prevention of bovine respiratory disease in dairy calves and cows. Vet Clin North Am Food Anim Pract 2010;26:243-259.
3. Griebel PJ. Mucosal vaccination of the newborn: an unrealized opportunity. Expert Rev Vaccines 2009;8:1-3.
4. Francis T Jr. The inactivation of epidemic influenza virus by nasal secretions of human individuals. Science 1940;91:198-199.
5. McKercher DG. Nasal versus parenteral vaccination for the protection of cattle against viral infection of the respiratory tract. Arch Vet Ital 1972;23:63-74.
6. Gutekunst DE, Paton IM, Volenec FK. Parainfluenza 3 vaccine in cattle: comparative efficacy of intranasal and intramuscular routes. J Am Vet Med Assoc 1969;155:1879-1885.
7. Todd JD, Volenec FJ, Pathon IM. Interferon in nasal secretions and sera of calves after intranasal administration of avirulent infectious bovine rhinotracheitis virus: association of interferon in nasal secretions with early resistance to challenge with virulent virus. Infect Immun 1972;5:699-706.
8. Ellis J, Gow S, West K, et al. Response of calves to challenge exposure with virulent bovine respiratory syncytial virus following intranasal administration of vaccines formulated for parenteral administration. J Am Vet Med Assoc 2007;230:233-243.
9. Ellis JA, Gow SP, Goji N. Response of experimentally induced infection with bovine respiratory syncytial virus following intranasal vaccination of seropositive and seronegative calves. J Am Vet Med Assoc 2010;236:991-999.
10. Ellis JA, West K, Konoby C, et al. Efficacy of an inactivated respiratory syncytial virus vaccine in calves. J Am Vet Med Assoc 2001;218:1973-1980.
11. Njaa BL, Clark EG, Janzen E, et al. Diagnosis of persistent bovine viral diarrhea virus infection by immunohistochemical staining of formalin-fixed skin biopsy specimens. J Vet Diagn Invest 2000;12:393-399.
12. West K, Petrie L, Haines DM, et al. The effect of formalininactivated vaccine on respiratory disease associated with bovine respiratory syncytial virus infection in calves. Vaccine 1999;17:809-820.
13. Will JA, Bisgard GE. Cardiac catheterization of unanesthetized large domestic animals. J Appl Physiol 1972;33:400-401.
14. West K, Ellis J. Functional analysis of antibody responses of feedlot cattle to bovine respiratory syncytial virus following vaccination with mixed vaccines. Can J Vet Res 1997;61:28-33.
15. West K, Bogdan J, Hamel A, et al. A comparison of diagnostic methods for the detection of bovine respiratory syncytial virus in experimental clinical specimens. Can J Vet Res 1998;62:245-250.
16. Ellis JA, Gow SP, Goji N, et al. Efficacy of a combination viral vaccine for protection of cattle against experimental infection with field isolates of bovine herpesvirus-1. J Am Vet Med Assoc 2009;235:563-572.
17. Tizard I. Immunity fetus and newborn. In: Veterinary immunology: an introduction. Philadelphia: WB Saunders Co, 2009;228-236.
18. Kimman TG, Westenbrink F, Staver PJ. Priming for local and systemic antibody memory responses to bovine respiratory syn cytial virus: effect of amount of virus, virus replication, route of administration and maternal antibodies. Vet Immunol Immunopathol 1989;22:145-160.
19. Godden SM, Haines DM, Hagman D. Improving passive transfer of immunoglobulins in calves. I: dose effect of feeding a commercial colostrum replacer. J Dairy Sci 2009;92:1750-1757.
20. Baker JC, Ames TR, Markham RJ. Seroepizootiologic study of bovine respiratory syncytial virus in a dairy herd. Am J Vet Res 1986;47:240-245.
21. Van der Poel WH, Kramps JA, Middel WG, et al. Dynamics of bovine respiratory syncytial virus infections: a longitudinal epidemiological study in dairy herds. Arch Virol 1993;133:309-321.
22. Belknap EB, Baker JC, Patterson JS, et al. The role of passive immunity in bovine respiratory syncytial virus-infected calves. J Infect Dis 1991;163:470-476.
23. Siegrist C-A. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine 2003;21:3406-3412.
24. West K, Petrie L, Konoby C, et al. The efficacy of modified-live bovine respiratory syncytial virus vaccines in experimentally infected calves. Vaccine 1999;18:907-919.
25. Henderson FW, Collier AM, Clyde WA Jr, et al. Respiratorysyncytial-virus infections, reinfections and immunity. A prospective, longitudinal study in young children. N Engl J Med 1979;300:530-534.
26. Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-546.
27. Mills J 5th, Van Kirk JE, Wright PF, et al. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol 1971;107:123-130.
28. Hall CB, Walsh EE, Long CE, et al. Immunity to and frequency of reinfection with respiratory syncytial virus. J Infect Dis 1991;163:693-698.
29. Lee FE, Walsh EE, Falsey AR, et al. Experimental infection of humans with A2 respiratory syncytial virus. Antiviral Res 2004;63:191-196.
30. Tizard I. Immunity at body surfaces. In: Veterinary immunology, an introduction. Philadelphia: WB Saunders Co, 2009;239-254.
31. Vajdy M. Generation and maintenance of mucosal memory B cell responses? Curr Med Chem 2006;13:3023-3037.
32. Bont L, Versteegh J, Swelsen WT, et al. Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity. Pediatr Res 2002;52:363-367.
33. Heckert RA, Saif LJ, Hoblet KH, et al. A longitudinal study of bovine coronavirus enteric and respiratory infections in dairy calves in two herds in Ohio. Vet Microbiol 1990;22:187-201.
34. Lu S. Heterologous prime-boost vaccination. Curr Opin Immunol 2009;21:346-351.
35. Doms RW. Immunology. Prime, boost, and broaden. Science 2010;329:1020-1021.